New study gives hope for women with advanced breast cancer
Jul 28, 2011
In breast cancer breakthroughs news, a new study has emerged that gives hope for women with advanced breast cancer.
A study published in Clinical Cancer Research shows that the use of trastuzumab (a type of antibody), chemotherapy and surgery can improve survival rates for women diagnosed with HER2-positive metastatic breast cancer, even if the cancer has spread to the central nervous system, Science Daily reports.
Lead researcher Dr. Adam Brufsky stated, "We clearly now know that these women should get trastuzumab and potentially chemotherapy, even if cancer spreads to the brain. Women with HER2-positive breast cancer have a reasonable chance of living a long time with their disease."
The study asserts that roughly 10 to 16 percent of women with advanced breast cancer have the illness spread to their central nervous system. One thousand and twenty three women diagnosed with HER2-positive metastatic breast cancer were examined in the study, 377 of whom had developed cancer in their central nervous system.
According to the Centers for Disease Control and Prevention, 202,964 women were diagnosed with breast cancer in the United States in 2007, and 40,598 died from the illness. Breast cancer is the second leading cause of cancer-related deaths among women in the United States, after lung cancer.